PHARMIONYX
LIVE

Serial Number

99579090

Owner

PharmiOnxy LLC

First Use Date

Aug 11, 2025

Filing Date

Jan 6, 2026

Add to watchlist:

No watchlists yet
View on USPTO

PHARMIONYX Trademark

Serial Number: 99579090

PHARMIONYX is a trademark filed by PharmiOnxy LLC on January 6, 2026. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

PharmiOnxy LLC

8605 Santa Monica Blvd #676303,
West Hollywood, CA 90069

Entity Type: 16

Trademark Details

Filing Date

January 6, 2026

Registration Date

Not Registered

First Use Anywhere

August 11, 2025

First Use in Commerce

August 11, 2025

Goods & Services

Arranging and conducting of seminars and workshops in the field of pharmaceutical and biotechnology; Professional coaching services in the field of leadership development; Providing online non-downloadable videos in the field of pharmaceuticals; Entertainment services, namely, providing podcasts in the field of pharmaceuticals; Educational services, namely, providing motivational and educational speakers for the pharmaceutical and biotechnology sectors in the field of Chemistry Manufacturing and Controls (CMC), and Analytical Development to strengthen technical, operational, and strategic competencies across drug development disciplines; Arranging and conducting of seminars, workshops, training courses, and coaching for the pharmaceutical and biotechnology sectors in the field of Chemistry Manufacturing and Controls (CMC), and Analytical Development to build technical and strategic skills in drug development; Arranging and conducting of seminars and workshops to provide training for certification in the field of Chemistry Manufacturing and Controls (CMC) strategy and documentation, and submission of regulatory documents in compliance with agency guidelines; Arranging and conducting of seminars and workshops in the field of business leadership, innovation, and quality culture

Technical consulting in the field of pharmaceutical and biotechnology studies; Consulting services in the field of pharmaceutical and biotechnology research; Consulting services in the field of pharmaceutical and biotechnology research and development; Consulting services for others in the field of design, planning, and implementation project management of computer software testing for Chemistry, Manufacturing, and Controls (CMC), analytical method development, bioanalytical strategy, and quality risk assessment; Consulting services for others in the field of design, planning, and implementation project management of technological research of computer software and computer hardware systems used for analytical method lifecycle management, method qualification and validation planning, and data interpretation; Consulting services for others in the field of design, planning, and implementation project management of scientific research and clinical trials; Consulting services for others in the field of design, planning, and implementation project management of computer software testing of software for assessing regulatory compliance for filings; Consulting on root cause analysis in the field of Pharmaceutical and Biotechnology products; Consulting services in the field of biotechnology; Technical consultancy in the field of scientific research; Technical consultancy in the field of industrial research; Research and development and consultation related thereto in the field of selection and implementation of computer hardware and software systems for others for laboratory informatics, data management tools, and automation in the field of pharmaceutical and biotechnology operations

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 22, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 12, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 12, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 12, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 18, 2026 GNRN
NON-FINAL ACTION E-MAILED
May 18, 2026 GNRT
NON-FINAL ACTION WRITTEN
May 18, 2026 CNRT
ASSIGNED TO EXAMINER
May 4, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 24, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Jan 6, 2026 MAFR
NEW APPLICATION ENTERED
Jan 6, 2026 NWAP